drugset / Trial / NCT00864487

Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib

NCT00864487

Phase 1 Completed 24 enrolled Puma Biotechnology, Inc.
Non-randomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to examine whether co-administration of rifampin with neratinib has an effect on the pharmacokinetics (how the body absorbs, distributes, metabolizes and/or excretes) of neratinib.

Timeline

Start
2009-04
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Neratinib Small molecule

Indications

No indication recorded.